N J Agnantis

515 total citations
24 papers, 429 citations indexed

About

N J Agnantis is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, N J Agnantis has authored 24 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in N J Agnantis's work include Bladder and Urothelial Cancer Treatments (4 papers), Protease and Inhibitor Mechanisms (3 papers) and Bone Tumor Diagnosis and Treatments (3 papers). N J Agnantis is often cited by papers focused on Bladder and Urothelial Cancer Treatments (4 papers), Protease and Inhibitor Mechanisms (3 papers) and Bone Tumor Diagnosis and Treatments (3 papers). N J Agnantis collaborates with scholars based in Greece, United States and Italy. N J Agnantis's co-authors include Demetrios�� Spandidos, E. Ioachim, Nicholas Pavlidis, Sevasti Kamina, Mei Bai, George Fountzilas, A. Goussia, Dimitrios Stefanou, Dimitrios Peschos and K. Charalabopoulos and has published in prestigious journals such as Oncology Reports, Journal of Cancer Research and Clinical Oncology and Tumor Biology.

In The Last Decade

N J Agnantis

24 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N J Agnantis Greece 13 223 169 87 82 69 24 429
R. Donnellan South Africa 7 308 1.4× 302 1.8× 106 1.2× 59 0.7× 92 1.3× 12 576
A. J. M. Balm Netherlands 11 416 1.9× 279 1.7× 79 0.9× 60 0.7× 175 2.5× 22 720
Kunio Araki Japan 15 215 1.0× 227 1.3× 139 1.6× 47 0.6× 198 2.9× 36 599
Ulla Aspenblad Sweden 11 181 0.8× 199 1.2× 120 1.4× 74 0.9× 114 1.7× 13 510
S. Smith United States 3 345 1.5× 242 1.4× 90 1.0× 68 0.8× 161 2.3× 5 506
V. Kannan India 8 129 0.6× 164 1.0× 153 1.8× 48 0.6× 180 2.6× 15 450
Kanae Nosaka Japan 12 153 0.7× 178 1.1× 98 1.1× 48 0.6× 135 2.0× 36 425
Dimitrios Krikelis Greece 13 227 1.0× 167 1.0× 103 1.2× 86 1.0× 152 2.2× 21 441
Esther O’Regan Ireland 15 113 0.5× 151 0.9× 91 1.0× 89 1.1× 58 0.8× 20 497
Ricardo Alvarez United States 11 133 0.6× 92 0.5× 58 0.7× 65 0.8× 98 1.4× 20 374

Countries citing papers authored by N J Agnantis

Since Specialization
Citations

This map shows the geographic impact of N J Agnantis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N J Agnantis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N J Agnantis more than expected).

Fields of papers citing papers by N J Agnantis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N J Agnantis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N J Agnantis. The network helps show where N J Agnantis may publish in the future.

Co-authorship network of co-authors of N J Agnantis

This figure shows the co-authorship network connecting the top 25 collaborators of N J Agnantis. A scholar is included among the top collaborators of N J Agnantis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N J Agnantis. N J Agnantis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nina, Helidon, et al.. (2023). NEW FRONTIERS FOR BREAST CANCER SURGERY IN ALBANIA NEW FRONTIERS FOR BREAST CANCER SURGERY IN ALBANIA. Archives of the Balkan Medical Union. 58(2). 178–186. 1 indexed citations
2.
Ioachim, E., Nikolaos Stavropoulos, K. Charalabopoulos, & N J Agnantis. (2009). Immunohistochemical prognostic markers in bladder cancer.. PubMed. 7(3). 207–16. 2 indexed citations
3.
Anagnostopoulos, George, Dimitrios Stefanou, John A. Karagiannis, et al.. (2008). Expression of Bax protein in gastric carcinomas. A clinicopathological and immunohistochemical study.. PubMed. 70(3). 285–9. 10 indexed citations
4.
Mitselou, Antigony, E. Ioachim, Dimitrios Peschos, et al.. (2007). E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies.. PubMed. 29(1). 54–60. 28 indexed citations
5.
Tsanou, Elena, E. Ioachim, Evangelos Briasoulis, et al.. (2004). Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.. PubMed. 23(4). 641–50. 27 indexed citations
6.
Παπαδοπούλου, Σοφία, et al.. (2001). Expression of Gelatinase-A (MMP-2) in Human Colon Cancer and Normal Colon Mucosa. Tumor Biology. 22(6). 383–389. 48 indexed citations
7.
Goussia, A., et al.. (2000). Bcl-2 expression in colorectal tumours. Correlation with p53, mdm-2, Rb proteins and proliferation indices.. PubMed. 15(3). 667–72. 11 indexed citations
8.
Stavropoulos, Nikolaos, et al.. (2000). Antiproliferative activity of interferon gamma in superficial bladder cancer.. PubMed. 19(5C). 4529–33. 6 indexed citations
9.
Ioachim, E., et al.. (1999). Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.. PubMed. 19(3A). 2133–9. 16 indexed citations
10.
Stefanou, Dimitrios, et al.. (1999). p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.. PubMed. 18(6B). 4673–81. 19 indexed citations
11.
Ioachim, E., et al.. (1998). Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.. PubMed. 18(3A). 1665–70. 17 indexed citations
12.
Pavlidis, Nicholas, et al.. (1996). Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin.. PubMed. 15(6B). 2563–7. 47 indexed citations
13.
Skopelitou, A., et al.. (1996). p53 Expression in Hepatocellular Carcinoma in Greece. Pathology - Research and Practice. 192(11). 1100–1106. 4 indexed citations
14.
Skopelitou, A., et al.. (1994). Expression of proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in multiple myeloma.. PubMed. 14(3A). 787–92. 6 indexed citations
15.
Agnantis, N J, et al.. (1992). Pleomorphic adenoma of the human female breast. Pathology - Research and Practice. 188(1-2). 235–240. 13 indexed citations
16.
Agnantis, N J, et al.. (1992). Comparative study of 5-year survival in no special type ductal and mixed type breast cancer. The Breast. 1(4). 196–198. 1 indexed citations
17.
Agnantis, N J, et al.. (1990). Immunohistochemical study of the ras oncogene expression in human bladder endoscopy specimens.. PubMed. 16(2). 153–60. 5 indexed citations
18.
Agnantis, N J, et al.. (1988). Therapeutic Effect of Bovine Albumin in the Experimental Fat Embolism Syndrome. Respiration. 53(1). 50–57. 10 indexed citations
19.
Agnantis, N J, et al.. (1986). Chondrosarcoma of the thumb: An unusual case with lung and cutaneous metastases and death of the patient 6 years after treatment. Journal of Cancer Research and Clinical Oncology. 112(1). 71–74. 14 indexed citations
20.
Spandidos, Demetrios�� & N J Agnantis. (1984). Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Harvey ras oncogene.. PubMed. 4(4-5). 269–72. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Donnellan Breakdown of academic impact, for papers by A. J. M. Balm Breakdown of academic impact, for papers by Kunio Araki Breakdown of academic impact, for papers by Ulla Aspenblad Breakdown of academic impact, for papers by S. Smith Breakdown of academic impact, for papers by V. Kannan Breakdown of academic impact, for papers by Kanae Nosaka Breakdown of academic impact, for papers by Dimitrios Krikelis Breakdown of academic impact, for papers by Esther O’Regan Breakdown of academic impact, for papers by Ricardo Alvarez
Rankless by CCL
2026